Markets:

Overview

News

Currencies

International

Treasuries

Insulet Corporation - Common Stock (NQ:PODD)

166.84 +1.16 (+0.70%)

Streaming Delayed Price Updated: 9:32 AM EDT, Jul 31, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Insulet Corporation - Common Stock

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

24 25 Next >

The 3 Best Diabetes Stocks to Buy in June 2024 ↗

June 19, 2024

There's less fear now about weight-loss drugs reducing the need for diabetes devices. Here are three diabetes stocks to buy.

Via InvestorPlace

Looking Into Insulet's Recent Short Interest ↗

June 17, 2024

Via Benzinga

7 Stocks That Could Safely 10X by 2030 ↗

June 06, 2024

Unlock the potential for exponential growth with these seven 10x stocks that could skyrocket by 2030 if the stars align.

Via InvestorPlace

Where Insulet Stands With Analysts ↗

May 30, 2024

Via Benzinga

Insulet to Present at the Jefferies Global Healthcare Conference

May 28, 2024

From Insulet Corporation

Via Business Wire

NASDAQ:PODD, a strong growth stock, setting up for a breakout. ↗

May 21, 2024

INSULET CORP (NASDAQ:PODD), a strong growth stock, setting up for a breakout.

Via Chartmill

Is NASDAQ:PODD suited for growth investing? ↗

May 20, 2024

INSULET CORP (NASDAQ:PODD) may be suited for growth investing, we'll explore why in this article.

Via Chartmill

4 Analysts Assess Insulet: What You Need To Know ↗

May 07, 2024

Via Benzinga

MicroStrategy Was The Best Among These 10 Large-Cap Stocks Scoring Big Last Week (May 12-May 19, 2024): Are They In Your Portfolio? ↗

May 19, 2024

Top performing large-cap stocks in the last week: MSTR, MNDY, ONON, SE, PODD, DELL, VOD, ALC, SMCI, CRBG. Analysts raise price targets & more positive news.

Via Benzinga

Follow the Whales: 3 Genius Stocks the Smart Money Is Piling Into for Triple-Digit Gains ↗

May 19, 2024

Ride the coattails of institutional investors with these three overlooked stocks smart money investors are piling into for triple-digit gains.

Via InvestorPlace

Will Insulet's Monopoly Crumble? Appellate Court Ruling Signals Shift in Automated Insulin Delivery Systems Market ↗

May 14, 2024

Latest on Insulet and its legal battle with EOFlow. Understand the impact of the appellate court's decision on market dynamics and Insulet's future.

Via Benzinga

Wall Street Trades Flat On Mixed Producer Inflation; Meme Stocks See Wild Ride, Bitcoin Drops: What's Driving Markets Tuesday? ↗

May 14, 2024

Wall Street is experiencing a subdued trading session, with all major indices showing minimal movement around midday in New York.

Via Benzinga

Why NASDAQ:PODD Is a Promising High-Growth Stock in the Midst of Consolidation. ↗

April 26, 2024

Is INSULET CORP (NASDAQ:PODD) on the Verge of a Major Breakout as a Strong Growth Stock?

Via Chartmill

Stocks Pause On Dismal Consumer Confidence; Yields, Dollar Rise As Inflation Expectations Kick Higher, Bitcoin Sinks: What's Driving Markets Friday? ↗

May 10, 2024

A worse-than-expected University of Michigan’s May consumer report halted stock gains on Friday, sparking worries about a potential decline in consumer health amid perceived rising price pressures.

Via Benzinga

Topics Economy

PODD Stock Earnings: Insulet Beats EPS, Beats Revenue for Q1 2024 ↗

May 09, 2024

PODD stock results show that Insulet beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.

Via InvestorPlace

Insulet Reports First Quarter 2024 Revenue Increase of 23% Year-Over-Year

May 09, 2024

From Insulet Corporation

Via Business Wire

10 Health Care Stocks With Whale Alerts In Today's Session ↗

May 09, 2024

Via Benzinga

Insulet’s 2023 Sustainability Report Highlights Commitment to Product Accessibility and Responsible Growth

May 07, 2024

From Insulet Corporation

Via Business Wire

3 Weight-Loss ETFs to Profit From the Obesity Drug Boom ↗

April 17, 2024

Leverage Oprah's shift to prescription weight solutions with Weight-Loss ETFs, targeting companies leading in obesity treatment.

Via InvestorPlace

Topics ETFs

7 Stable Stocks for 50% Returns by Early 2025 ↗

April 15, 2024

These 7 stable stocks also offer 50% returns according to analysts according to analysts tasked with following their respective industries.

Via InvestorPlace

Why NASDAQ:PODD Is a Promising High-Growth Stock in the Midst of Consolidation. ↗

April 05, 2024

INSULET CORP (NASDAQ:PODD)—Positioned as a High-Growth Stock, Ready for a Potential Breakout.

Via Chartmill

Insulet to Announce First Quarter 2024 Financial Results on May 9, 2024

April 03, 2024

From Insulet Corporation

Via Business Wire

Large-Cap Stocks In Trouble: Here Are The 10 Worst Performers Over The Past 12 Months ↗

March 31, 2024

Over the past 12 months, 10 Large-Cap stocks have underperformed all others.

Via Talk Markets

5 Stocks To Buy On The Dip To Gain From The Wall Street Rally ↗

March 23, 2024

Wall Street had a dream run in 2023, reversing the nightmare of 2022. The impressive bull run appears set to continue in 2024. Thus, here is a look at some stocks that may be worth buying on the dip...

Via Talk Markets

Insulet Appoints Ana Maria Chadwick as Chief Financial Officer

March 20, 2024

From Insulet Corporation

Via Business Wire

Why NASDAQ:PODD Is a Promising High-Growth Stock in the Midst of Consolidation. ↗

March 14, 2024

INSULET CORP (NASDAQ:PODD) qualifies as a high growth stock and is consolidating.

Via Chartmill

Are These 5 Undervalued Stocks Ready to Break Out?

March 08, 2024

Undervalued stocks Albemarle, Ionis, Insulet, Hess and Wynn beat earnings views, offering potential for investors to buy quality companies at discounted prices.

Via MarketBeat

Insulet’s Randomized Controlled Trial (OP5-003) Demonstrates Omnipod® 5 Automated Insulin Delivery System is Superior to Pump Therapy

March 08, 2024

From Insulet Corporation

Via Business Wire

Insulet to Present Results from First Omnipod® 5 Randomized Controlled Trial (OP5-003) at the 17th International Conference on Advanced Technologies & Treatments for Diabetes (ATTD)

March 05, 2024

From Insulet Corporation

Via Business Wire

Is It Time to Buy the S&P 500's 3 Worst-Performing February Stocks? ↗

March 04, 2024

A handful of large-cap stocks are now on sale. The discount, however, doesn't necessarily make them worth buying.

Via The Motley Fool

Topics Stocks

< Previous 1 2

...

12 13 14 15 16 17 18 19 20

...

24 25 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.